These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38991773)

  • 21. Does Age Interfere With Gadolinium Toxicity and Presence in Brain and Bone Tissues?: A Comparative Gadoterate Versus Gadodiamide Study in Juvenile and Adult Rats.
    Fretellier N; Granottier A; Rasschaert M; Grindel AL; Baudimont F; Robert P; Idée JM; Corot C
    Invest Radiol; 2019 Feb; 54(2):61-71. PubMed ID: 30394964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gadolinium deposition in the brain: association with various GBCAs using a generalized additive model.
    Bae S; Lee HJ; Han K; Park YW; Choi YS; Ahn SS; Kim J; Lee SK
    Eur Radiol; 2017 Aug; 27(8):3353-3361. PubMed ID: 28083696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gadolinium Retention in the Brain of Mother and Pup Mouse: Effect of Pregnancy and Repeated Administration of Gadolinium-Based Contrast Agents.
    Yao X; Zhang H; Shi D; Li Y; Guo Q; Yu Z; Wang S; Ren K
    J Magn Reson Imaging; 2022 Sep; 56(3):835-845. PubMed ID: 35166409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative analysis of Gd in the protein content of the brain following single injection of gadolinium-based contrast agents (GBCAs) by size exclusion chromatography.
    Kartamihardja AAP; Hanaoka H; Andriana P; Kameo S; Takahashi A; Koyama H; Tsushima Y
    Br J Radiol; 2019 Jul; 92(1099):20190062. PubMed ID: 31045442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraindividual Analysis of Signal Intensity Changes in the Dentate Nucleus After Consecutive Serial Applications of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
    Radbruch A; Weberling LD; Kieslich PJ; Hepp J; Kickingereder P; Wick W; Schlemmer HP; Bendszus M
    Invest Radiol; 2016 Nov; 51(11):683-690. PubMed ID: 27495187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gadolinium retention in gliomas and adjacent normal brain tissue: association with tumor contrast enhancement and linear/macrocyclic agents.
    Kiviniemi A; Gardberg M; Ek P; Frantzén J; Bobacka J; Minn H
    Neuroradiology; 2019 May; 61(5):535-544. PubMed ID: 30710184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term Gadolinium Retention in the Healthy Rat Brain: Comparison between Gadopiclenol, Gadobutrol, and Gadodiamide.
    Funke SKI; Factor C; Rasschaert M; Lezius L; Sperling M; Karst U; Robert P
    Radiology; 2022 Oct; 305(1):179-189. PubMed ID: 35727155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gadolinium Presence in Rat Skin: Assessment of Histopathologic Changes Associated with Small Fiber Neuropathy.
    Boyken J; Lohrke J; Treu A; Neddens J; Jost G; Ulbrich HF; Balzer T; Frenzel T; Prokesch M; Thuss U; Pietsch H
    Radiology; 2024 Jan; 310(1):e231984. PubMed ID: 38226877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive Analysis of the Spatial Distribution of Gadolinium, Iron, Manganese, and Phosphorus in the Brain of Healthy Rats After High-Dose Administrations of Gadodiamide and Gadobutrol.
    Hummel L; Frenzel T; Boyken J; Pietsch H; Seeliger E
    Invest Radiol; 2024 Feb; 59(2):150-164. PubMed ID: 38157437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain tissue gadolinium retention in pediatric patients after contrast-enhanced magnetic resonance exams: pathological confirmation.
    Stanescu AL; Shaw DW; Murata N; Murata K; Rutledge JC; Maloney E; Maravilla KR
    Pediatr Radiol; 2020 Mar; 50(3):388-396. PubMed ID: 31989188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Revisiting the Pharmacokinetic Profiles of Gadolinium-Based Contrast Agents: Differences in Long-Term Biodistribution and Excretion.
    Lancelot E
    Invest Radiol; 2016 Nov; 51(11):691-700. PubMed ID: 27175546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ischemic Stroke Increased Gadolinium Deposition in the Brain and Aggravated Astrocyte Injury After Gadolinium-Based Contrast Agent Administration: Linear Versus Macrocyclic Agents.
    Huang XX; Jiang RH; Xu XQ; Zu QQ; Wu FY; Liu S; Shi HB
    J Magn Reson Imaging; 2021 Apr; 53(4):1282-1292. PubMed ID: 33555617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elemental Bioimaging of Sheep Bone and Articular Cartilage After Single Application of Gadolinium-Based Contrast Agents.
    Richter H; Verlemann C; Jeibmann A; Martin LF; Luebke AM; Karol A; Sperling M; Radbruch A; Karst U
    Invest Radiol; 2024 Apr; 59(4):287-292. PubMed ID: 37747456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One-year Retention of Gadolinium in the Brain: Comparison of Gadodiamide and Gadoterate Meglumine in a Rodent Model.
    Robert P; Fingerhut S; Factor C; Vives V; Letien J; Sperling M; Rasschaert M; Santus R; Ballet S; Idée JM; Corot C; Karst U
    Radiology; 2018 Aug; 288(2):424-433. PubMed ID: 29786486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric Brain: Gadolinium Deposition in Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted Images Is Dependent on the Type of Contrast Agent.
    Ryu YJ; Choi YH; Cheon JE; Lee WJ; Park S; Park JE; Kim WS; Kim IO
    Invest Radiol; 2018 Apr; 53(4):246-255. PubMed ID: 29300210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical Questions Regarding Gadolinium Deposition in the Brain and Body After Injections of the Gadolinium-Based Contrast Agents, Safety, and Clinical Recommendations in Consideration of the EMA's Pharmacovigilance and Risk Assessment Committee Recommendation for Suspension of the Marketing Authorizations for 4 Linear Agents.
    Runge VM
    Invest Radiol; 2017 Jun; 52(6):317-323. PubMed ID: 28368880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Gadolinium Retention in the Brains of Type 2 Diabetic Rats after Repeated Administration of Gadolinium-Based MRI Contrast Agents on Neurobiology and NLRP3 Inflammasome Activation.
    Yao X; Zhang H; Hu J; Lin X; Sun J; Kang J; Huang Z; Wang G; Tian X; Chen E; Ren K
    J Magn Reson Imaging; 2024 Nov; 60(5):2156-2170. PubMed ID: 38400842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gadolinium retention within multiple rat organs after intra-articular administration of gadolinium-based contrast agents.
    Ringler MD; Rhodes NG; Ayers-Ringler JR; Jakaitis DR; McDonald RJ; Kallmes DF; McDonald JS
    Skeletal Radiol; 2021 Jul; 50(7):1419-1425. PubMed ID: 33404669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signal Enhancement and Enhancement Kinetics of Gadobutrol, Gadoteridol, and Gadoterate Meglumine in Various Body Regions: A Comparative Animal Study.
    Knobloch G; Frenzel T; Pietsch H; Jost G
    Invest Radiol; 2020 Jun; 55(6):367-373. PubMed ID: 31985602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different Impact of Gadopentetate and Gadobutrol on Inflammation-Promoted Retention and Toxicity of Gadolinium Within the Mouse Brain.
    Anderhalten L; Silva RV; Morr A; Wang S; Smorodchenko A; Saatz J; Traub H; Mueller S; Boehm-Sturm P; Rodriguez-Sillke Y; Kunkel D; Hahndorf J; Paul F; Taupitz M; Sack I; Infante-Duarte C
    Invest Radiol; 2022 Oct; 57(10):677-688. PubMed ID: 35467573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.